In line with other Src tyrosine kinase inhibitors shown to increase oxidative stress [15], the changes in ROS and RNS levels detected in Si306- and pro-Si306-treated GBM cells after 24 h are likely connected to inhibition of the Src pathway. The gene discussed is SRC; the disease is glioblastoma.